WCG publishes report providing assessment of motivators across all clinical research stakeholders, including patients, sites and sponsors.
WCG has released its 2023 Avoca State of the Industry Report. The report provides insights into what steps can be taken to encourage potential volunteers to participate in clinical trials, particularly among underrepresented groups.
The survey, conducted between December 2022 and March 2023, recruited respondents from stakeholders across the clinical trial continuum – sponsors, providers, site staff, and patients – to identify opportunities to improve both the participant and site experience. Findings demonstrate the ability to develop a clinical trial experience that is more "personal" will increase motivation to participate.
"For more than 20 years, Avoca has surveyed industry stakeholders to gain an understanding of key trends affecting outsourced clinical development," explains Christine Albano, general manager, WCG Benchmarking & Analytics. "This latest research included a broadened outreach to collect more diverse perspectives, focusing on the imperative of patient centricity and the need for expanding clinical trial participation."
The full 2023 Avoca State of the Industry Report can be accessed for free, after providing an email, on Avoca's website.
Reference: WCG Publishes Report Providing Assessment of Motivators Across All Clinical Research Stakeholders, PRINCETON, N.J., July 12, 2023, PRNewswire.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Real-World Data Show 99% Efficacy for Apretude in HIV Prevention with High Adherence, Reduced Stigma
October 16th 2024Real-world data presented at IDWeek 2024 show Apretude (cabotegravir long-acting) is more than 99% effective in preventing HIV infection, with high adherence rates, reduced stigma and anxiety, and broad acceptability.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.